News : Events

Avalun is coordinating the Di@pason project, which will test a connected patient care pathway on a cohort of 10,000 patients on blood thinners in six regions across France. Caregivers will test Avalun’s LabPad INR portable lab, which utilizes consumables manufactured at the BHT building. The connected patient care pathway could ultimately be expanded to all […] >>

Clinatec’s Brain-Computer Interface (BCI) project was recently featured in The Lancet Neurology* and has appeared in the media worldwide. This groundbreaking project shows just how powerful the Clinatec model—medical doctors and technology experts working side-by-side under one roof—is at driving innovation.   The WIMAGINE® implantable medical device is the first technology brick in Clinatec’s BCI […] >>

Construction on the BHT2 building was completed last spring, and startup Prophesee moved its R&D department into a 154 sq. m space at the end of September. Prophesee’s R&D team will be working on the integration of its neuromorphic vision technology into autonomous vehicles in partnership with Leti.   eLichens and Diabeloop to move in […] >>

Aledia has been housed at MINATEC Entreprises for seven years. Today, the company is investing €20 million in a 4,000 sq. m facility in Echirolles, near Grenoble. The new facility, which will be equipped with Aledia’s own machines, will be dedicated to R&D as Aledia prepares to launch production within the next two years. Compared […] >>

Researchers from Leti, CEA Sciences, and INSERM injected Lipidots® (lipid-based nanoparticles) containing the p24 protein of the Human Immunodeficiency Virus (HIV) into an animal model and obtained a robust and complete immune response. Lipidots® were created by Leti and CNRS in 2006 to encapsulate and deliver drugs or fluorescent chemical compounds to “target” cells. The […] >>